Browse the evidence

The transition to fatherhood during young adulthood (ages 19-39) is associated with longitudinal declines in cardiovascular health, specifically characterized by reduced physical activity, increased sedentary behavior, reduced sleep, poor diet quality, and increased body weight.

If you are becoming a first-time father, expect your health metrics to potentially decline due to lifestyle disruptions. Prioritize sleep and simple dietary choices early on, as these are the areas most likely to suffer. Recognize that stress and anxiety are common triggers for poor health behaviors during this period, and plan for them proactively rather than reacting to them.

Higher adherence to the PURE diet score is significantly associated with lower odds of depression and anxiety in adults at high cardiovascular risk, with the association being statistically significant in women but not in men.

Focus on adding fruits, vegetables, legumes, nuts, fish, and whole-fat dairy to your daily diet. This pattern, known as the PURE diet, is linked to lower risks of depression and anxiety, especially in women. You do not need to strictly eliminate animal products or dairy to see benefits; the key is overall dietary quality and nutrient density rather than extreme restriction.

Greater restriction of the daily eating window is positively associated with greater loss of fat mass and visceral fat in individuals practicing TRE.

Tightening your eating window further (e.g., from 10 hours to 8 hours) may yield greater fat loss benefits, provided you maintain the ad libitum approach.

Intermittent fasting (IF) produces weight loss (0.8% to 13.0% of baseline) that is equivalent to continuous calorie restriction, regardless of whether total caloric intake is restricted on non-fasting days.

Intermittent fasting is a viable weight loss strategy for overweight and obese individuals, producing results similar to traditional calorie restriction. You can choose from various protocols, such as a 16-hour daily fast or fasting two days a week with reduced calories. The key is consistency; hunger often decreases over time, and adherence is comparable to other diets. While most studies are short-term, IF shows promise as a primary care intervention for obesity.

Intermittent fasting improves glycemic control in patients with Type 2 Diabetes, including reductions in fasting glucose, HbA1c, and insulin levels, though it carries a risk of hypoglycemia requiring medication adjustment.

If you have Type 2 Diabetes, intermittent fasting can improve your blood sugar control, but you must work with your doctor to adjust medications like insulin or sulfonylureas to avoid low blood sugar. Studies show that with proper management, IF is safe and can lower HbA1c and fasting glucose levels without severe adverse events.

High-intensity lifestyle interventions are associated with a modest, statistically non-significant reduction in all-cause mortality (OR 0.86), though the point estimate suggests a potential benefit.

While high-intensity lifestyle interventions may reduce mortality, the evidence is not yet statistically definitive due to low death rates in trials. However, the observed 14% reduction is promising and aligns with other long-term health data.

A remotely delivered, 12-month GLP-1RA (semaglutide) supported weight management program achieves significant weight loss (mean 19.1% of starting weight) in participants who maintain an active subscription, but high withdrawal rates (60.4%) limit generalizability.

If you have obesity and are considering a GLP-1RA like semaglutide, a remote program can help you lose significant weight (around 19% on average) if you stick with it. However, be aware that many people drop out, often due to side effects or cost. To succeed, you need to be committed to the weekly injections and the digital support, and understand that stopping the medication likely leads to weight regain.

Polyglucosamine supplementation (800-1700 mg/day) combined with caloric restriction and physical activity produces a statistically significant, albeit modest, reduction in body weight (-1.78 kg) and BMI (-1.52 kg/m2) compared to lifestyle interventions alone in overweight and obese adults.

If you are overweight, taking polyglucosamine (approx 1-1.7g daily, split into doses with meals) alongside a calorie-restricted diet and moderate exercise will help you lose slightly more weight (about 1.8 kg more) than diet and exercise alone over 3-12 months. It is not a magic solution, but a small booster.

Virtual weight care programs prescribing a broad range of antiobesity medications alongside behavior change achieve clinically significant weight loss (mean 8.0% at 12 months) in real-world settings, with higher engagement correlating with greater weight loss.

Engage with a structured virtual weight care program that combines medication with behavioral support. Higher engagement with the program (logging weight weekly, interacting with coaches) correlates with greater weight loss (up to 12%). You do not need the most expensive medications to achieve significant results; a broad range of medications, when paired with consistent engagement, can lead to clinically meaningful weight loss.

Tirzepatide produces significantly greater long-term total body weight loss and fat mass reduction compared to Semaglutide in real-world clinical practice, with effects becoming distinct after 6 months.

If you are choosing between Semaglutide and Tirzepatide for long-term weight management, Tirzepatide offers significantly greater weight loss after 12 months. To maximize results and protect your muscle, you must combine the medication with a program that includes strength training twice a week and a protein intake of 60-90 grams daily.

Females experience significantly greater weight loss than males when treated with incretin-based obesity medications (Semaglutide and Tirzepatide).

If you are male, expect that your weight loss may be slower than that of female peers taking the same medication. This is a known biological response. Do not be discouraged; the medication still provides significant metabolic benefits and fat loss, even if the scale moves slower.

Low-carbohydrate diets (5-25% energy from carbohydrate) improve cardiometabolic markers (weight, HDL, triglycerides) in healthy adults over 12 weeks, with greater carbohydrate restriction yielding larger improvements in HDL and triglycerides.

Adopting a low-carbohydrate diet (5-25% of calories from carbs) for 12 weeks can improve your weight, waist size, and key blood markers like HDL and triglycerides, even if you don't change your total calorie intake. While stricter diets (5% carbs) yield the best blood marker improvements, moderate restriction (15-25% carbs) is easier to stick to and still provides significant health benefits.

Omega-3 PUFA supplementation reduces total mortality and cardiovascular-related hospitalizations in patients with chronic heart failure with reduced ejection fraction.

If you have heart failure with a weak heart pump (reduced ejection fraction), taking fish oil supplements may help you live longer and avoid hospitalizations. It is a reasonable addition to your treatment plan. Ask your doctor if it's right for you.

Intensive, multicomponent behavioral weight loss interventions produce statistically significant, albeit modest, weight loss (-2.4 kg) and reduce the incidence of type 2 diabetes in adults with overweight or obesity, without increasing serious adverse events.

Engage in a structured behavioral program focusing on diet and physical activity. While the average weight loss is modest (around 5 lbs), the program significantly lowers your risk of developing type 2 diabetes. Consistency over 12-36 months is key, and serious side effects are not a concern with this approach.

FDA-approved weight loss medications (liraglutide, lorcaserin, naltrexone-bupropion, orlistat, phentermine-topiramate) produce greater weight loss and diabetes risk reduction than placebo, but are associated with higher rates of adverse events and dropout.

If behavioral interventions alone are insufficient, FDA-approved weight loss medications can provide greater weight loss and diabetes risk reduction. However, be prepared for a higher likelihood of side effects and discontinuation. These medications should be used in conjunction with behavioral interventions.

Very low carbohydrate diets (VLCDs) are less effective for weight loss than less restrictive LCDs, but this is explained by lower adherence rather than the diet itself.

If you try a very strict low carb diet (under 50g carbs/day) and find it too hard to maintain, you might lose less weight. This isn't because the diet doesn't work, but because it's harder to stick to. If you can't maintain the strict version, a less restrictive low carb diet (under 130g/day) is a viable alternative that still offers significant benefits for diabetes remission and weight loss.

Metabolic stress and metabolites may act as hypertrophy stimuli, particularly when combined with blood flow restriction or low-load exercise, but the specific metabolite candidates are poorly characterized.

While metabolic stress (the 'burn') is often associated with muscle growth, the paper suggests it is not the primary driver. Low-load training with blood flow restriction can induce hypertrophy, likely through metabolic factors, but this is less well-understood than mechanical load. Focus on mechanical tension first; metabolic stress may be a useful adjunct.

Dairy consumption has complex cardiometabolic effects that differ from isolated nutrient recommendations, with specific components like dairy fats and proteins offering potential benefits that contradict traditional low-fat dairy guidelines.

Include dairy in your diet, but focus on the whole food matrix rather than just fat content. Fermented dairy (yogurt, cheese) and whole milk may have different metabolic impacts than isolated nutrients suggest. Variety in dairy sources is key.

Consumption of dairy products, particularly yogurt and cheese, is associated with a reduced risk of type 2 diabetes and colorectal cancer, while the link to prostate cancer risk remains limited or specific to whole milk intake.

Incorporate yogurt and cheese into your diet to potentially lower the risk of type 2 diabetes and colorectal cancer. Focus on plain varieties to minimize added sugars. The calcium and bioactive compounds in dairy support long-term metabolic and digestive health.

Replacing dietary carbohydrates with saturated fats reduces the risk of stroke and all-cause mortality, whereas replacing carbohydrates with unsaturated fats or animal-derived proteins increases mortality risk.

If you are currently eating a high-carbohydrate diet, consider replacing some of those refined carbs with plant-based fats (like those from nuts or seeds) rather than animal fats. This substitution has been linked to a lower risk of stroke and mortality in large population studies, challenging the old advice to simply cut all fat.

Gradual, individualized dose escalation of GLP-1 receptor agonists is the primary clinical strategy to mitigate gastrointestinal side effects (nausea, vomiting, constipation) and improve treatment persistence in obesity management.

When starting a GLP-1 injection for weight loss, do not rush to the full dose. Start at the lowest possible dose and wait until you feel completely comfortable before asking your doctor to increase it. Eat smaller, low-fat meals and stay hydrated. If you feel nauseous, pause the increase; this is normal and usually goes away.

Dietary modifications, specifically reducing meal size and avoiding high-fat or spicy foods, are effective non-pharmacological interventions for managing mild gastrointestinal side effects during GLP-1RA treatment.

To avoid stomach upset from GLP-1s, eat smaller portions, stop when you feel full, and avoid greasy or spicy foods, especially when starting. Drink plenty of water and increase fiber if you are constipated.

Resistance training load (intensity) does not significantly impact skeletal muscle hypertrophy, provided sets are performed to or near volitional fatigue.

You do not need to lift heavy weights to build muscle. Whether you use light weights for many reps or heavy weights for few reps, muscle growth is similar as long as you work close to failure. This allows you to choose loads that feel good for your joints.

Adherence to a 9-hour Time-Restricted Eating window reduces daily energy intake by lowering absolute carbohydrate and alcohol consumption, but does not change total energy intake if adherence is low.

If you choose to use TRE for Type 2 Diabetes, strict adherence to the 9-hour window is required to see any reduction in calories, specifically by cutting back on carbs and alcohol. If you frequently break the window, you will likely consume the same amount of energy as before, resulting in no weight or metabolic benefit.